Clinical Trial Update: The Multicenter, Open-label, Single-use Autoinjector Convenience Study [Phase 3]

View source ↗

Summary

Phase 3 multicenter open-label study assessing autoinjector convenience for an MS therapy; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: EMD Serono | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2010-12-30